GEMS full strain culture medium
Posted: Thu Feb 13, 2025 4:22 am
Opening a new cooperation model of "Group Strategic Cooperation" to promote the deep integration of medical groups
In 2025, Beikang Medical will continue to vigorously promote the core strategy of the "Global Industrial Chain Empowerment Plan", promote the implementation of the group's direct sales model, and work with more medical groups around the world to upgrade and build "intelligent" assisted reproductive centers, promote industry progress and innovation, improve the level of global medical services, and bring more benefits to patients.
For example, the company has established a group cooperation with Gattaca Genomics LLC, a leading reproductive genetics company in North America, to jointly plan to provide one-stop solutions including Geri full-time difference incubators to approximately 100 reproductive centers around the world; reached a group cooperation with the well-known CCRM chinese malaysia data Medical Group in the United States; created an intelligent overall solution with the First Fertility Medical Group in the United States; established a group cooperation with the world's largest IVIRMA Medical Group in Europe to create a 100% full-time difference culture coverage plan, leading the trend of embryo culture technology.
Reached a group cooperation with the Safe Fertility Group Medical Group in Southeast Asia; and further strengthened the exclusive strategic cooperation with the Australian Genea Group to jointly explore the next generation of innovative technology research and development and transformation in the field of assisted reproduction. In addition, the company has reached a group cooperation with China's well-known Jinghua Medical Group to build China's benchmark demonstration center for intelligent assisted reproduction. These collaborations not only demonstrate Beikang Medical's profound accumulation and forward-looking vision in the field of assisted reproduction, but also lay a solid foundation for the company's future global development.
Beikang Medical BMX executives collectively appeared at the ASRM American Reproductive Annual Meeting
Finally, against the backdrop of countries around the world introducing policies to encourage childbirth, Beikang Medical is entering the fast lane of rapid development with its comprehensive industrial chain layout in the field of assisted reproduction, unremitting technological innovation and active market expansion strategy.
In 2025, Beikang Medical will continue to vigorously promote the core strategy of the "Global Industrial Chain Empowerment Plan", promote the implementation of the group's direct sales model, and work with more medical groups around the world to upgrade and build "intelligent" assisted reproductive centers, promote industry progress and innovation, improve the level of global medical services, and bring more benefits to patients.
For example, the company has established a group cooperation with Gattaca Genomics LLC, a leading reproductive genetics company in North America, to jointly plan to provide one-stop solutions including Geri full-time difference incubators to approximately 100 reproductive centers around the world; reached a group cooperation with the well-known CCRM chinese malaysia data Medical Group in the United States; created an intelligent overall solution with the First Fertility Medical Group in the United States; established a group cooperation with the world's largest IVIRMA Medical Group in Europe to create a 100% full-time difference culture coverage plan, leading the trend of embryo culture technology.
Reached a group cooperation with the Safe Fertility Group Medical Group in Southeast Asia; and further strengthened the exclusive strategic cooperation with the Australian Genea Group to jointly explore the next generation of innovative technology research and development and transformation in the field of assisted reproduction. In addition, the company has reached a group cooperation with China's well-known Jinghua Medical Group to build China's benchmark demonstration center for intelligent assisted reproduction. These collaborations not only demonstrate Beikang Medical's profound accumulation and forward-looking vision in the field of assisted reproduction, but also lay a solid foundation for the company's future global development.
Beikang Medical BMX executives collectively appeared at the ASRM American Reproductive Annual Meeting
Finally, against the backdrop of countries around the world introducing policies to encourage childbirth, Beikang Medical is entering the fast lane of rapid development with its comprehensive industrial chain layout in the field of assisted reproduction, unremitting technological innovation and active market expansion strategy.